Pharmaceutical

Cue Biopharma downsizes to focus on autoimmune pipeline

The company has fired 25% of its staff and plans to look for partnerships to further its oncology candidates.

Jul 28, 2024 - 04:00
Cue Biopharma downsizes to focus on autoimmune pipeline
The company has fired 25% of its staff and plans to look for partnerships to further its oncology candidates.
Read the original article

Tags:

Previous Article

Inside the efforts to rescue a rare disease gene therapy 

Next Article

Roche records 4% decline in H1 2024 net income

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Biotech launches with $82 million for Parkinson’s cell therapy

STAT+: Biotech launches with $82 million for Parkinson’...

Feb 29, 2024

STAT+: A new list ranks large pharmaceutical companies by research and development

STAT+: A new list ranks large pharmaceutical companies ...

May 5, 2023

STAT+: ‘I never realized what people go through’: Doctor and former hospital CEO with Stage 4 cancer calls for greater empathy in medicine

STAT+: ‘I never realized what people go through’: Docto...

Nov 15, 2023